DK0961611T3 - Ekspanderbart gastroretentivt terapeutisk system med kontrolleret frisætning af aktivt stof i den gastrointestinale kanal - Google Patents

Ekspanderbart gastroretentivt terapeutisk system med kontrolleret frisætning af aktivt stof i den gastrointestinale kanal

Info

Publication number
DK0961611T3
DK0961611T3 DK98906865T DK98906865T DK0961611T3 DK 0961611 T3 DK0961611 T3 DK 0961611T3 DK 98906865 T DK98906865 T DK 98906865T DK 98906865 T DK98906865 T DK 98906865T DK 0961611 T3 DK0961611 T3 DK 0961611T3
Authority
DK
Denmark
Prior art keywords
gastrointestinal
controlled release
expandable
active substance
therapeutic system
Prior art date
Application number
DK98906865T
Other languages
Danish (da)
English (en)
Inventor
Bodo Asmussen
Karsten Cremer
Hans-Rainer Hoffmann
Karin Ludwig
Michael Roreger
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Application granted granted Critical
Publication of DK0961611T3 publication Critical patent/DK0961611T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D7/00—Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/009—Sachets, pouches characterised by the material or function of the envelope
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nutrition Science (AREA)
  • Wood Science & Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK98906865T 1997-01-14 1998-01-09 Ekspanderbart gastroretentivt terapeutisk system med kontrolleret frisætning af aktivt stof i den gastrointestinale kanal DK0961611T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19700915 1997-01-14
PCT/EP1998/000099 WO1998031341A1 (de) 1997-01-14 1998-01-09 Expandierbares gastroretentives therapie-system mit kontrollierter wirkstofffreisetzung im gastrointestinaltrakt

Publications (1)

Publication Number Publication Date
DK0961611T3 true DK0961611T3 (da) 2002-07-15

Family

ID=7817288

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98906865T DK0961611T3 (da) 1997-01-14 1998-01-09 Ekspanderbart gastroretentivt terapeutisk system med kontrolleret frisætning af aktivt stof i den gastrointestinale kanal

Country Status (20)

Country Link
US (1) US6290989B1 (cs)
EP (1) EP0961611B1 (cs)
JP (1) JP3825811B2 (cs)
KR (1) KR100503266B1 (cs)
AT (1) ATE214916T1 (cs)
AU (1) AU727753B2 (cs)
CA (1) CA2277277C (cs)
CZ (1) CZ297098B6 (cs)
DE (2) DE19800523C2 (cs)
DK (1) DK0961611T3 (cs)
ES (1) ES2175676T3 (cs)
HU (1) HU224224B1 (cs)
ID (1) ID22698A (cs)
IL (1) IL130872A (cs)
NO (1) NO993383L (cs)
NZ (1) NZ336691A (cs)
PL (1) PL193282B1 (cs)
PT (1) PT961611E (cs)
SK (1) SK93999A3 (cs)
WO (1) WO1998031341A1 (cs)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19822278A1 (de) * 1998-05-18 1999-12-02 Lohmann Therapie Syst Lts Vorrichtung zur kontrollierten Freisetzung von Wirkstoff im Gastrointestinaltrakt mit verzögerter Pyloruspassage
DE19837073A1 (de) * 1998-08-17 2000-03-23 Lohmann Therapie Syst Lts Folienförmige Wirkstoffträger
DE19849848A1 (de) * 1998-10-29 2000-05-04 Lohmann Therapie Syst Lts Oral applizierbare, mit Flüssigkeit spontan zerfallende therapeutische Darreichungsform und Verfahren zu ihrer Herstellung
DE19850309A1 (de) * 1998-10-30 2000-05-04 Lohmann Therapie Syst Lts Expandierbares gastroretensives Therapiesystem mit verlängerter Magenverweildauer
DE19920855A1 (de) * 1999-05-06 2000-11-16 Lohmann Therapie Syst Lts Magenvolumenreduzierende Darreichungsform
DE19920837A1 (de) * 1999-05-06 2000-11-16 Lohmann Therapie Syst Lts Gastroretentives System für verlängerte Verweilzeit im Magen bzw. im Gastrointestinaltrakt
DE19920833A1 (de) * 1999-05-06 2000-11-16 Lohmann Therapie Syst Lts Gastroretentives System mit quellbaren Polymeren
DE19920854A1 (de) * 1999-05-06 2000-11-16 Lohmann Therapie Syst Lts Verfahren und Vorrichtung zum Herstellen eines gastroretentiven flachen Schlauchbeutels mit Längsnaht
DE19920838A1 (de) * 1999-05-06 2000-11-16 Lohmann Therapie Syst Lts Gastroretentives System mit Kapillaren
CA2396782A1 (en) * 2000-02-04 2001-08-09 Depomed, Inc. Shell-and-core dosage form approaching zero-order drug release
GB0102725D0 (en) * 2001-02-02 2001-03-21 Stowic Resources Ltd Medical delivery system
EP1245227A1 (en) 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
WO2003051329A1 (de) * 2001-12-17 2003-06-26 Beisel Guenther Mittel zur oralen einnahme und verfahren zu dessen herstellung
US6869333B2 (en) * 2002-09-11 2005-03-22 National Optronics, Inc. Lens blank alignment and blocking device and method
JP2006506362A (ja) * 2002-10-11 2006-02-23 デポメド・ディベロップメント・リミテッド 胃内保持型レボドパデリバリー形態
TW200533391A (en) 2004-03-25 2005-10-16 Sun Pharmaceutical Ind Ltd Gastric retention drug delivery system
EP1786378A2 (en) * 2004-07-30 2007-05-23 Merrion Research II Limited Improved process and machine for automated manufacture of gastro-retentive devices
US8852083B2 (en) * 2005-02-04 2014-10-07 Uti Limited Partnership Self-stabilized encapsulated imaging system
WO2006088305A1 (en) * 2005-02-15 2006-08-24 Chong Kun Dang Pharmaceutical Corp. Gastric-retentive controlled release mono-matrix tablet
WO2007084818A2 (en) * 2006-01-10 2007-07-26 Pipex, Inc. Pharmaceutical compositions and methods to achieve and maintain a targeted and stable copper status and prevent and treat copper-related central nervous system diseases
US9579227B2 (en) * 2006-03-29 2017-02-28 Eat Little Inc. Ingestible implement for weight control
CA2647487C (en) * 2006-03-29 2014-10-21 Electronic Dietary Foods Inc. Ingestible implement for weight control
CA2672602C (en) * 2006-12-18 2014-05-20 Electronic Dietary Foods Inc. Device for delivery of a substance
US20080286343A1 (en) * 2007-05-16 2008-11-20 Dzenana Cengic Solid form
WO2011048494A2 (en) * 2009-10-19 2011-04-28 Intec Pharma Ltd. Novel gastroretentive dosage forms of poorly soluble drugs
US20140343452A1 (en) * 2011-12-21 2014-11-20 Eatlittle Inc. Pseudobezoar-Based Intraluminal Gastrointestinal Cleansing and Biospy
WO2022124914A1 (en) 2020-12-08 2022-06-16 Ruminant Biotech Corp Limited Improvements to devices and methods for delivery of substances to animals

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4207890A (en) 1977-01-04 1980-06-17 Mcneilab, Inc. Drug-dispensing device and method
DE3400106A1 (de) 1984-01-04 1985-07-11 Klaus-Dieter Dr. 3550 Marburg Bremecker Pharmazeutische zubereitungen mit gesteuerter arzneistoff-freisetzung
DE3676626D1 (de) 1985-10-09 1991-02-07 Desitin Arzneimittel Gmbh Verfahren zur herstellung einer darreichungs- und dosierungsform fuer arzneimittel-wirkstoffe, reagentien oder andere wirkstoffe.
IL87710A (en) * 1987-09-18 1992-06-21 Ciba Geigy Ag Covered floating retard form for controlled release in gastric juice
DE3812799A1 (de) * 1988-04-16 1989-10-26 Sanol Arznei Schwarz Gmbh Oral zu verabreichende pharmazeutische zubereitung mit kontrollierter wirkstofffreisetzung und verfahren zu deren herstellung
EP0408496A3 (en) * 1989-07-12 1992-07-01 Ciba-Geigy Ag Solid dosage form for pharmaceutical substances
WO1993012765A1 (en) * 1991-12-27 1993-07-08 Merck & Co., Inc. A controlled release drug dispersion delivery device
GB9202519D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
US5260069A (en) * 1992-11-27 1993-11-09 Anda Sr Pharmaceuticals Inc. Pulsatile particles drug delivery system
DE4406424A1 (de) * 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen

Also Published As

Publication number Publication date
DE19800523C2 (de) 1999-01-21
IL130872A0 (en) 2001-01-28
US6290989B1 (en) 2001-09-18
CA2277277A1 (en) 1998-07-23
PL193282B1 (pl) 2007-01-31
PT961611E (pt) 2002-09-30
HUP0000943A3 (en) 2000-11-28
CA2277277C (en) 2005-03-08
EP0961611A2 (de) 1999-12-08
DE59803511D1 (de) 2002-05-02
PL334834A1 (en) 2000-03-27
EP0961611B1 (de) 2002-03-27
ID22698A (id) 1999-12-09
CZ249599A3 (cs) 2000-01-12
HUP0000943A2 (hu) 2000-10-28
NO993383D0 (no) 1999-07-08
ES2175676T3 (es) 2002-11-16
KR20000070179A (ko) 2000-11-25
KR100503266B1 (ko) 2005-07-25
IL130872A (en) 2004-02-19
AU6292298A (en) 1998-08-07
SK93999A3 (en) 2000-01-18
CZ297098B6 (cs) 2006-09-13
WO1998031341A1 (de) 1998-07-23
JP2001508068A (ja) 2001-06-19
DE19800523A1 (de) 1998-07-30
JP3825811B2 (ja) 2006-09-27
HU224224B1 (hu) 2005-06-28
NO993383L (no) 1999-07-08
AU727753B2 (en) 2000-12-21
NZ336691A (en) 2000-05-26
ATE214916T1 (de) 2002-04-15

Similar Documents

Publication Publication Date Title
DK0961611T3 (da) Ekspanderbart gastroretentivt terapeutisk system med kontrolleret frisætning af aktivt stof i den gastrointestinale kanal
CA2344672A1 (en) Expandable gastroretentive therapy system having a prolonged gastric residence time
WO2001056544A3 (en) Shell-and-core dosage form approaching zero-order drug release
NO995753L (no) Gastroretarderende mikrosfærer med styrt frigivelse for bedret administrasjon av medikament
DK1093370T3 (da) Farmaceutisk præparat til behandling af diabetes
FI973452L (fi) Nauhoitettu annosmuoto aktiivisen aineen pidennettyyn jakamiseen
NO996352D0 (no) <Kappa>-antagenist-forbindelser, farmasoeytiske sammensetninger og fremgangsmåte for forebygging og behandling av pruritus
DK0956858T3 (da) Farmaceutiske præparater indeholdende lactobacilli til behandling af vaginale infektioner
DK1207867T3 (da) Retarderede, orale farmaceutiske indgivelsesformer med tramadol
NO20002721L (no) Heterocykliske forbindelser for inhibering av mavesyresekresjon, fremgangsmÕter for deres fremstilling og farmasøytiske preparater derav
DK0941103T3 (da) Farmaceutisk præparat til behandling af diabetes
BR9912979B1 (pt) composição farmacêutica administrável oralmente, tablete de mascar, cápsula e uso de chitosan.
DK1024794T3 (da) Fremgangsmåde til behandling af kapsler og törre, pulveriserede farmaceutiske formuleringer
NO932979D0 (no) Orale doseringsformer med forsinket frigjoering for behandling av tarmforstyrrelser
EE04676B1 (et) Imidasopridiini derivaadid, mis inhibeerivad maohappesekretsiooni, protsess nende valmistamiseks ning nende kasutamine
DE59707812D1 (de) Opioidantagonisthaltige galenische formulierung
DK2272870T3 (da) Fremgangsmåde til fremstilling af immunoglobuliner med henblik på intravenøs indgivelse og andre immunoglobulin-lignende produkter.
MA26709A1 (fr) Compositions pharmaceutiques de celecoxib, leurs procedes de preparation et methodes de traitement les utilisant
PT1441705E (pt) Sistemas terapêuticos sólidos, estabilizados, de libertação rápida e/ou modificada para a administração oral de princípios ativos, excipientes ou produtos alimentares líquidos
BR0012981A (pt) Sistema para liberação oral de droga hidrodinamicamente balanceado
DK0616802T3 (da) Oralt præparat til frigivelse i de nedre fordøjelseskanaler
GT200100033A (es) Sistema de administracion oral controlada para la ingestion diaria de ciprofloxacina.
DK0768882T3 (da) Carbamazepin-lægemiddelform med forsinket aktivmiddelfrigivelse
NO913019D0 (no) Faste orale preparatformer som inneholder ifosfamid som virksomt stoff.
DK0979069T3 (da) Fremgangsmåde til fremstilling af peroralt anvendelige faste lægemiddelformer med styret afgivelse af aktivt stof